How big is the Colorectal Cancer Screening Market?

The Colorectal Cancer Screening Market size is expected to reach USD 15.48 billion in 2024 and grow at a CAGR of 5.16% to reach USD 19.91 billion by 2029. Read More

What is the current Colorectal Cancer Screening Market size?

In 2024, the Colorectal Cancer Screening Market size is expected to reach USD 15.48 billion. Read More

Who are the key players in Colorectal Cancer Screening Market?

Epigenomics Inc., Exact Sciences Corporation, Hemosure Inc., Eiken Chemical Co. Ltd and QuidelOrtho Corporation are the major companies operating in the Colorectal Cancer Screening Market. Read More

Which is the fastest growing region in Colorectal Cancer Screening Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Colorectal Cancer Screening Market?

In 2024, the North America accounts for the largest market share in Colorectal Cancer Screening Market. Read More

What years does this Colorectal Cancer Screening Market cover, and what was the market size in 2023?

In 2023, the Colorectal Cancer Screening Market size was estimated at USD 14.72 billion. The report covers the Colorectal Cancer Screening Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Colorectal Cancer Screening Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Colorectal Cancer Screening Market Share

Statistics for the 2023 & 2024 Colorectal Cancer Screening market share, created by Mordor Intelligence™ Industry Reports. Colorectal Cancer Screening share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Colorectal Cancer Screening Industry

The colorectal cancer screening market is moderately consolidated due to the presence of many small and large players. Some of them include Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, Hemosure Inc., Quidel Corporation, Siemens Healthineers AG, and Sysmex Corporation.